FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

33 letters match. Newest first.

  1. Pro-Optics, LLC

    FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.

    Medium
  2. Peter Schiff Enterprises

    FDA warns Peter Schiff Enterprises over unapproved cardiac devices and serious quality system failures.

    High risk
  3. Nihon Kohden Digital Health Solutions, LLC

    FDA says Nihon Kohden Digital Health Solutions sold an uncleared monitor software change that can silence life-threatening alarms.

    High risk
  4. BlephEx, LLC

    FDA says BlephEx sold three eye devices without required FDA clearance and missed device reports.

    High risk
  5. Estar Technologies Ltd

    FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.

    High risk
  6. Unetixs Vascular, Inc.

    Unetixs Vascular marketed modified ROODRA and 2CP vascular diagnostic devices without required FDA clearance.

    High risk
  7. Physitemp Instruments, LLC

    FDA says Physitemp sold clinical thermometers and temperature probes without FDA clearance and with unvalidated sterilization and welding.

    High risk
  8. ASP Global, LLC. dba Anatomy Supply Partners, LLC.

    FDA cites ASP Global for quality-system, reporting, and unapproved-change violations involving Safe-T-Fill blood collection devices.

    High risk
  9. Technological Medical Advancements LLC

    Technological Medical Advancements LLC marketed Diowave laser systems for unapproved uses without required FDA clearance and had serious quality-system failures.

    High risk
  10. Les Encres LLC

    FDA warns Les Encres that its PDO surgical suture threads were promoted for unapproved cosmetic uses and had quality system violations.

    High risk
  11. Insightra Medical Inc.

    FDA warns Insightra Medical over unapproved IABP catheter claims and missed adverse-event reports.

    High risk
  12. DRG Instruments GmbH

    FDA warns DRG Instruments over unapproved salivary cortisol ELISA devices and quality system and reporting violations.

    High risk
  13. Rex Implants Inc.

    Rex Implants warned for unapproved dental implant devices and uncleared changes to its cleared implant system.

    High risk
  14. Dexcom, Inc.

    FDA warned Dexcom over quality-system and design-control failures for G6 and G7 glucose monitors, including an unapproved sensor component change.

    High risk
  15. Xoran Technologies, LLC

    FDA warned Xoran Technologies that its computed tomography devices and software violate quality rules and lack required marketing clearance.

    High risk
  16. Cardinal Health

    Cardinal Health marketed convenience kits with unapproved syringes and lacked supplier qualification for infusion-pump-compatible Monoject syringes.

    High risk
  17. Agena Bioscience, Inc.

    Agena Bioscience marketed its iPLEX HS Colon Panel with the MassARRAY4 System for clinical diagnosis without FDA clearance or approval.

    High risk
  18. ReNovo, Inc. DBA Provision Device Reprocessing Solutions

    ReNovo, a device reprocessor in Bend, Oregon, sold new device models without required FDA clearances and had quality system failures.

    High risk
  19. Sol-Millennium Medical, Inc.

    Sol-Millennium marketed modified syringes and needles without required FDA clearance and had quality-system and reporting violations.

    High risk
  20. Dr. Joel Kaplan Inc.

    FDA warned Dr. Joel Kaplan Inc. that its sexual health devices are unapproved, misbranded, and made under quality system violations.

    High risk
  21. Terragene S.A.

    Terragene S.A. made sterilization indicator devices with complaint-handling and MDR failures and uncleared extended-cycle claims.

    High risk
  22. Acrostak Schweiz AG

    FDA warns Acrostak Schweiz that its M-Cath Flexy Microcatheter was marketed without required 510(k) clearance (FDA marketing permission) and has quality-system violations.

    High risk
  23. Neurotris, Inc. dba A1 Engineering

    FDA warns Neurotris over unapproved, misbranded facial/body stimulator devices and quality system violations.

    High risk
  24. Tesla BioHealing, Inc.

    FDA warns Tesla BioHealing over unapproved MedBed and BioHealer devices marketed for serious diseases.

    High risk
  25. King Systems Corp. dba Ambu, Inc.

    FDA warns Ambu's King Systems over unapproved King LTS-D airway device and pediatric website claims.

    High risk
  26. iRhythm Technologies, Inc.

    FDA warned iRhythm that its Zio AT cardiac monitor was illegally marketed after a 2022 inspection found unapproved changes and quality failures.

    High risk
  27. Medivance Instruments Ltd.

    Medivance marketed modified Velopex dental abrasion devices without required FDA clearance and had quality-system violations.

    High risk
  28. Abbott Point of Care Canada Limited

    FDA says Abbott Point of Care Canada marketed modified i-STAT cTnI cartridges without required FDA clearance.

    High risk
  29. Synovo Production, Inc.

    FDA warned Synovo Production of Fullerton, CA over unapproved cementless hip implants and quality system failures.

    High risk
  30. Zyno Medical LLC

    FDA warns Zyno Medical over infusion pump and administration set quality violations and unapproved set changes.

    High risk
  31. Skin Sheek

    Skin Sheek markets CLEAR, ERASE, LIFT and SILK skin devices without FDA clearance or approval, FDA says.

    High risk
  32. CardioQuip, LLC

    CardioQuip sold significantly modified cardiac heater-cooler devices without required FDA clearance and with quality system violations.

    High risk
  33. Captain's Cloth LLC

    FDA warned Captain's Cloth that it sold unapproved KN95 face masks online with misleading FDA-logo claims.

    Medium